Ticker Appearances
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Minor consolidation in Large-cap Technology possible ahead of broad-based breakout
SHORT-TERM TRENDS ARE BULLISH BUT EXTENDED FOLLOWING THE RECENT PUSHBACK TO NEW ALL-TIME HIGHS FOR SPX AND QQQ, WHILE MANY OTHER INDICES FAILED TO PARTICIPATE. WHILE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Signal From Noise
Technical Strategy
Upticks - November 2023
UPTICKS _(New Additions in Bold) _ LAGGARDS _(New Additions in Bold) _ MEANINGFUL MOVEMENT WORTH DISCUSSING AMONG CURRENT UPTICKS HOLDINGS FIRST SOLAR (FSLR 1.66% ) Source: TradingView...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Minor consolidation in Large-cap Technology possible ahead of broad-based breakout
SHORT-TERM TRENDS ARE BULLISH BUT EXTENDED FOLLOWING THE RECENT PUSHBACK TO NEW ALL-TIME HIGHS FOR SPX AND QQQ, WHILE MANY OTHER INDICES FAILED TO PARTICIPATE. WHILE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Signal From Noise
Technical Strategy
Upticks - November 2023
UPTICKS _(New Additions in Bold) _ LAGGARDS _(New Additions in Bold) _ MEANINGFUL MOVEMENT WORTH DISCUSSING AMONG CURRENT UPTICKS HOLDINGS FIRST SOLAR (FSLR 1.66% ) Source: TradingView...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Minor consolidation in Large-cap Technology possible ahead of broad-based breakout
SHORT-TERM TRENDS ARE BULLISH BUT EXTENDED FOLLOWING THE RECENT PUSHBACK TO NEW ALL-TIME HIGHS FOR SPX AND QQQ, WHILE MANY OTHER INDICES FAILED TO PARTICIPATE. WHILE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
